Conversely, MSC-Exo have been found to inhibit angiogenesis by downregulating vascular endothelial growth factor (VEGF) through specific miRNAs, offering potential therapeutic benefits in cancer treatment (Pakravan et al. 2017). The gene discussed is VEGFA; the disease is cancer.